An off-target effect of AZD6738 on mTOR can also be ruled out by the rescue with lanosterol/cholesterol in cancer cells (Figs. 4 and EV4), and by the sensitization upon p16 knockdown (Fig. EV4). This evidence concerns the gene CDKN2A and cancer.